Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration [PDF]
Bioprosthetic heart valves (BHVs) largely circumvent the need for long‐term anticoagulation compared with mechanical valves but are increasingly susceptible to deterioration and reduced durability with reoperation rates of ≈10% and 30% at 10 and 15 years,
Matteo Marro +5 more
doaj +8 more sources
Structural Valve Degeneration in the Era of Transcatheter Aortic Valve Replacement∗ [PDF]
Corresponding ...
Ozan M. Demir, MD, MS +1 more
doaj +7 more sources
The role of echocardiography in the management of structural valve degeneration of transcatheter valves [PDF]
Transcatheter valve implantation in patients with aortic stenosis has evolved as an acceptable alternative to surgical aortic valve replacement in a subset of patients at excessively high risk from surgery.
Rahul Shabadi +3 more
doaj +5 more sources
Early Biological Valve Failure: Structural Valve Degeneration, Thrombosis, or Endocarditis? [PDF]
Biological valve failure (BVF) is an inevitable condition that compromises the durability of biological heart valves (BHVs). It stems from various causes, including rejection, thrombosis, and endocarditis, leading to a critical state of valve dysfunction.
Fabio Fazzari +2 more
exaly +5 more sources
Effect of pregnancy on bioprosthetic structural valve degeneration [PDF]
Background: Despite increasing frequency of pregnancies among patients with cardiac conditions, including the presence of prosthetic heart valves, data on the effects of physiological changes during pregnancy on the function of bioprosthetic valves ...
Joshua J. Price +4 more
doaj +5 more sources
Acute Presentation of Structural Valve Degeneration in a Transcatheter Heart Valve (Sapien XT) at 7.5 Years; Successful Redo TAVR With a Sapien 3 UltraNovel Teaching Points [PDF]
Little is known about the presentation of structural valve degeneration complicating transcatheter heart valves (THVs). We report a case of acute heart failure, secondary to leaflet prolapse, in a previously well 77-year-old man, 7.5 years after ...
Sagar N. Doshi, BSc (Hons), MBChB, FRCP, MD +3 more
doaj +5 more sources
Midterm Durability and Structural Valve Degeneration of Transcatheter Aortic Valve Replacement in a Federal Facility [PDF]
Objective: Transcatheter aortic valve replacement (TAVR), previously reserved for patients of intermediate to prohibitive surgical risk, has now been expanded to patients of any surgical risk with severe aortic stenosis.
Aaron F Grober +2 more
exaly +7 more sources
Redo hybrid mitral valve-in-valve for early structural valve degeneration: Pearls and pitfalls of a novel techniqueCentral Message [PDF]
Surgical valve re-replacement remains the standard of care for most patients with bioprosthetic valve degeneration, whereas transcatheter valve-in-valve procedures remain a valid alternative in anatomically feasible high-risk patients.
Sophia L. Alexis, MD +4 more
doaj +5 more sources
Editorial: Structural Valve Degeneration and Failure in Transcatheter and Surgical Bioprosthesis [PDF]
Chiara Fraccaro +2 more
doaj +8 more sources
Outcomes of Redo Transcatheter Aortic Valve Implantation for Structural Valve Degeneration of Transcatheter Aortic Valve [PDF]
Background: The outcome of redo transcatheter aortic valve (TAV) implantation (TAVI) is unknown for TAV structural valve degeneration (SVD). This paper reports the initial results of redo TAVI for TAV-SVD in Japanese patients. Methods and Results: Of 630
Yoshiki Sawa, Masaki Tsuda
exaly +6 more sources

